|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/10/13 Link Jr. Charles J 4 Dir.,Off.² 1:7K Lumos Pharma, Inc. Lumos Pharma, Inc.
5/10/13 Talarico Ernest III 4 Director² 1:5K Lumos Pharma, Inc. Lumos Pharma, Inc.
5/10/13 Raffin Thomas A. 4 Director² 1:5K Lumos Pharma, Inc. Lumos Pharma, Inc.
5/10/13 Link Gordon H Jr. 4 Officer² 1:8K Lumos Pharma, Inc. Lumos Pharma, Inc.
5/10/13 Edick Paul R 4 Director² 1:5K Lumos Pharma, Inc. Lumos Pharma, Inc.
5/10/13 Saluri Joseph 4 Director² 1:5K Lumos Pharma, Inc. Lumos Pharma, Inc.
5/10/13 Zoth Lota S. 4 Director² 1:5K Lumos Pharma, Inc. Lumos Pharma, Inc.
3/27/13 Lumos Pharma, Inc. DEF 14A 5/9/13 1:1.4M
3/14/13 Lumos Pharma, Inc. PRE 14A 5/9/13 1:1.4M
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|